Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Cash from Investing Activities (2019 - 2025)

Inventiva (IVEVF) posted Cash from Investing Activities of -$28.1 million for Q2 2025, down 10166.56% on a QoQ basis from -$273426.3 in Q4 2022.

Analysis

Inventiva (IVEVF) Cash from Investing Activities (2019 - 2025) Analysis & Trends

Inventiva has reported Cash from Investing Activities for 5 years, with the latest figure at -$28.1 million in Q2 2025.

  • On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$28.1 million in Q2 2025; TTM through Jun 2025 was -$23.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$155.0 million, down 1759.03% from the prior year.
  • Cash from Investing Activities was -$28.1 million for Q2 2025 at Inventiva, down from -$273426.3 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $7.7 million in Q1 2021, with the low at -$28.1 million in Q2 2025.
  • Average Cash from Investing Activities over 3 years is -$2.9 million, with a median of -$276534.1 recorded in 2022.
  • The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities jumped 553.88% in 2021, then slumped 105.04% in 2022.
  • Over 3 years, Cash from Investing Activities stood at $5.4 million in 2021, then plunged by 105.04% to -$273426.3 in 2022, then tumbled by 10166.56% to -$28.1 million in 2025.
  • The last three Cash from Investing Activities figures came in at -$28.1 million (Q2 2025), -$273426.3 (Q4 2022), and -$279641.8 (Q3 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Johnson & Johnson 645.95 Bn 625.20 Bn 17.26 Bn -1.11 Bn
2 AbbVie 441.39 Bn 434.82 Bn 12.70 Bn -1.20 Bn
3 Merck 366.72 Bn 359.58 Bn 12.21 Bn -5.60 Bn
4 Novartis Ag 266.68 Bn 258.99 Bn 11.24 Bn -3.11 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn 2.11 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -424.26 Mn
7 Revolution Medicines 44.08 Bn 44.08 Bn - -1.66 Bn
8 Incyte 25.50 Bn 20.96 Bn 1.57 Bn -51.79 Mn
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn 87.50 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -28.07 Mn
Dec 31, 2022 -273,426.29
Sep 22, 2022 -279,641.81
Dec 31, 2021 5.42 Mn
Jun 30, 2021 -1.97 Mn
Mar 31, 2021 7.69 Mn
Dec 31, 2020 -1.19 Mn
Dec 31, 2019 -928,678.76